Acne Scrub

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Acne Scrub
Generic name: SALICYLIC ACID
Manufacturer: Spa de Soleil
Product type: HUMAN OTC DRUG
SPL set ID: 0a9067f7-2a9d-abae-e063-6394a90a3533
SPL ID: 48df0eff-9f06-e2fd-e063-6294a90ad526
Version: 3
Effective date: 2026-01-20
Source export date: 2026-10-27
Source partition: 3
Source file: https://download.open.fda.gov/drug/label/drug-label-0003-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-27/d7629e6f844435cfe6cb0cf8c5341c46775ea16c5af42c77a22a2ffe820a2cd2/drug-label-0003-of-0014.json.zip
Source manifest SHA-256: 6be3667a3beefe6c0ead4c723ea963050533a2bc725a8044d58b07d18b258c55
Import run: 20261027T193451Z
Imported at: 2026-10-27 19:50:01

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 10 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M006	openfda.application_number
brand name		Acne Scrub	openfda.brand_name
generic name		SALICYLIC ACID	openfda.generic_name
manufacturer name		Spa de Soleil	openfda.manufacturer_name
ndc	package	68062-2257-1	openfda.package_ndc
ndc	product	68062-2257	openfda.product_ndc
ndc11	package	68062225701	derived:openfda.package_ndc
spl id		48df0eff-9f06-e2fd-e063-6294a90ad526	id
spl set id		0a9067f7-2a9d-abae-e063-6394a90a3533	set_id
unii		O414PZ4LPZ	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only. Using other topical acne medications at the same time or immediately following use of this product may increase dryness or irritation of the skin. If this occurs, only one medication should be used unless directed by a doctor. Sensitivity Test for a New User. Apply product sparingly to one or two small affected areas during the first 3 days. If no discomfort occurs, follow the steps stated in directions.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.